Feb 25,2016

Insulet Announces Development Partner for the OmniPod Artificial Pancreas

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today announced a license agreement and partnership with Mode AGC (Automated Glucose Control LLC), to develop and incorporate the advanced artificial pancreas algorithm created by renowned researchers Francis Doyle PhD, Eyal Dassau PhD, and Howard Zisser MD. Insulet's artificial pancreas system will use the innovative and differentiated OmniPod platform, the latest DexCom Continuous Glucose Monitoring (CGM) technology and the algorithm licensed from Mode AGC.

COLLABORATION PARTNERSHIP

#r&d

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 25,2016

Insulet Reports Fourth Quarter and Full Year 2015 Financial Results

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today announced financial results for the three months and full year ended December 31, 2015. Fourth quarter 2015 revenue increased 38% to $100.1 million compared to $72.6 million in the fourth quarter of 2014. For the year ended December 31, 2015, revenue increased 12% to $324.2 million compared to $288.7 million in 2014.

View Analyst & Ambassador Comments
Go to original news
Feb 25,2016

Silicon Valley Accelerator Blackbox Connect selects 1Drop Diagnostics

1Drop Diagnostics saves lives through better and faster portable medical diagnostics. The Swiss and American company has just completed a two-week residential program designed to immerse international start-up founders into Silicon Valley culture. 1Drop was one of just 12 companies taking part in the program, which brings start-ups to California to meet investors, develop relationships in Silicon Valley and learn how to scale in the US.

View Analyst & Ambassador Comments
Go to original news
Feb 29,2016

Insulet Corporation to Present at Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced that management will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, Florida on March 7, 2016 at 7:30am (Eastern Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Mar 09,2016

AbilTo study shows its diabetes-focused remote visits program can lower depression, stress, anxiety

A diabetes-focused behavioral health remote visits program can help participants who complete it to lower their levels of stress, anxiety, and depression, while increasing their frequency of glucose self-testing, according to a retrospective study of 466 people published in Telemedicine and eHealth. The study was conducted by AbilTo, which offers a remote visits behavior health service.

CLINICAL STUDY

#telehealth

#coaching

View Analyst & Ambassador Comments
Go to original news
Mar 09,2016

JAMA study is the latest to examine health app privacy policies

Some 81 percent of diabetes apps in the Google Play store did not offer privacy policies, according to a study of 211 apps published in the Journal of the American Medical Association.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 15,2016

UCSF researchers tap prediabetes app-based coaching startup Yes Health for user data

UCSF Diabetes Center has announced a partnership with mobile-enabled health coaching company Yes Health to use the company's app user data for research. Yes Health offers a 16-week, app-based program for people with prediabetes and type 2 diabetes, that includes one-on-one coaching, nutrition and fitness tracking, as well as personalized health advice. The program costs $9.75 for the first four months, and $15 per month to continue.

COLLABORATION PARTNERSHIP

#r&d

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Mar 24,2016

Philadelphia's Dreamit Health announces 15 startups in its 2016 accelerator class

Suggestic, a personalized lifestyle and nutrition program for people with type 2 diabetes, is selected by Philadelphia-based accelerator Dreamit Health, to join its next accelerator class.

View Analyst & Ambassador Comments
Go to original news
Mar 31,2016

Stanford study: Dexcom CGM, HealthKit, and Epic can improve glycemic control in kids, teens

A group of Stanford physicians and researchers has published a study in the Journal of the American Medical Informatics Association detailing their experience setting up continuous glucose monitoring with a Dexcom G4 CGM, Apple HealthKit, and Epic.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 02,2016

Insulet Announces Organizational Enhancements

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today announced the promotion of Shacey Petrovic to the newly-created role of President, Insulet Diabetes Products and the recent appointment of Charles Alpuche as Senior Vice President of Global Manufacturing and Operations.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES